Methods for the treatment of nonalcoholic steatohepatitis
AssigneesInstitut National De La Sante Et De La Recherche Medicale (Inserm), Universite Paris Descartes
InventorsAlain Tedgui, Xavier Loyer, Pierre-Emmanuel Rautou
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.
Claims5
A method for reducing liver inflammation in a subject having liver inflammation comprising the step of administering to said subject a therapeutic amount of a chemically modified miR-21 inhibitor and a pharmaceutically acceptable carrier, wherein said step of administering reduces said liver inflammation in said subject.
Dependencies are inferred from the claim text.